Aristotle Capital Boston, LLC, an investment advisor, released its “Small Cap Equity Fund” Q2 2026 investor letter. A copy of the letter can be downloaded here. The Fund returned 13.69% in the second quarter of 2026, trailing the Russell 2000 Index’s 21.49% gain as security selection in information technology and industrials weighed on performance despite […]

Aristotle Capital Boston, LLC, an investment advisor, released its “Small Cap Equity Fund” Q2 2026 investor letter. A copy of the letter can be downloaded here. The Fund returned 13.69% in the second quarter of 2026, trailing the Russell 2000 Index’s 21.49% gain as security selection in information technology and industrials weighed on performance despite […]

Aristotle Capital Boston, LLC, an investment advisor, released its “Small Cap Equity Fund” Q2 2026 investor letter. A copy of the letter can be downloaded here. The Fund returned 13.69% in the second quarter of 2026, trailing the Russell 2000 Index’s 21.49% gain as security selection in information technology and industrials weighed on performance despite […]

Aristotle Capital Boston, LLC, an investment advisor, released its “Small Cap Equity Fund” Q2 2026 investor letter. A copy of the letter can be downloaded here. The Fund returned 13.69% in the second quarter of 2026, trailing the Russell 2000 Index’s 21.49% gain as security selection in information technology and industrials weighed on performance despite […]

Aristotle Capital Boston, LLC, an investment advisor, released its “Small Cap Equity Fund” Q2 2026 investor letter. A copy of the letter can be downloaded here. The Fund returned 13.69% in the second quarter of 2026, trailing the Russell 2000 Index’s 21.49% gain as security selection in information technology and industrials weighed on performance despite […]

Aristotle Capital Boston, LLC, an investment advisor, released its “Small Cap Equity Fund” Q2 2026 investor letter. A copy of the letter can be downloaded here. The Fund returned 13.69% in the second quarter of 2026, trailing the Russell 2000 Index’s 21.49% gain as security selection in information technology and industrials weighed on performance despite […]

Aristotle Capital Boston, LLC, an investment advisor, released its “Small Cap Equity Fund” Q2 2026 investor letter. A copy of the letter can be downloaded here. The Fund returned 13.69% in the second quarter of 2026, trailing the Russell 2000 Index’s 21.49% gain as security selection in information technology and industrials weighed on performance despite […]

Aristotle Capital Boston, LLC, an investment advisor, released its “Small Cap Equity Fund” Q2 2026 investor letter. A copy of the letter can be downloaded here. The Fund returned 13.69% in the second quarter of 2026, trailing the Russell 2000 Index’s 21.49% gain as security selection in information technology and industrials weighed on performance despite […]

Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lofty expectations make them particularly susceptible to drawdowns when market sentiment shifts.

The gain was set before the results crossed, and its optical peers rose with it.

AI data centers are steering the shift from copper to optical connectivity, putting photonics at the center of investor attention.

A weekend debate on social media about optics replacing memory as the hottest AI trade sent optical stocks surging at Monday's open, then something unexpected happened within the first ten minutes of trading.

Evaluate IPG's (IPGP) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

What IPG Photonics’ Latest Earnings Mean For Investors IPG Photonics (IPGP) reported second quarter 2026 earnings on 4 August, with higher sales but lower net income and earnings per share. The company also issued third quarter revenue guidance of US$265 million to US$295 million. See our latest analysis for IPG Photonics. Since the start of 2026, IPG Photonics has delivered a 15.85% year to date share price return, although recent momentum has faded, with the share price down 10.25% over 30...

IPG (IPGP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

IPG Photonics stock has delivered a strong gain over the past year yet remains well below its level from five years ago, and the current valuation checks flag the shares as leaning expensive rather than a clear bargain. Over the last five years, IPG Photonics shareholders have seen the stock fall 47.0%, which raises questions about how much fundamental progress is now already reflected in the current price. Future revenue growth and margin resilience can support today’s price, while any...

In the past week, IPG Photonics Corporation reported second-quarter 2026 results showing sales rising to US$278.58 million from US$250.72 million a year earlier, while net income eased to US$5.24 million from US$6.61 million and basic earnings per share from continuing operations moved to US$0.12 from US$0.16. Alongside this, IPG Photonics highlighted ongoing 11% year-over-year revenue growth driven by industrial and emerging laser applications, beat profit expectations, and announced a...

IPG Photonics beats Q2 earnings estimates as Industrial Solutions growth, led by battery manufacturing, lifts revenues and margins.

IPG rallied after delivering strong guidance.

IPG Photonics Corp (IPGP) reports 11% revenue growth, driven by industrial solutions and emerging products, while announcing a major medical acquisition.

IPG Photonics (NASDAQ:IPGP) reported second-quarter 2026 revenue of $279 million, up 11% from a year earlier and representing its third consecutive quarter of double-digit year-over-year sales growth. Revenue exceeded the midpoint of the company’s guidance, while bookings improved and book-to-bill r

IPG (IPGP) delivered earnings and revenue surprises of +45.00% and -0.21%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Fiber laser manufacturer IPG Photonics (NASDAQ:IPGP) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 11.1% year on year to $278.6 million. The company expects next quarter’s revenue to be around $280 million, coming in 1.2% above analysts’ estimates. Its non-GAAP profit of $0.58 per share was 49.3% above analysts’ consensus estimates.

(Bloomberg) -- SpaceX’s first earnings report following its blockbuster initial public offering is one of the most anticipated events of the summer on Wall Street. Whether it’ll give investors a reason to buy the sinking stock is another matter.Most Read from BloombergBeer Dynasty Families Sell €731 Million Stake in AB InBevApple’s New CEO Taps Retired Hardware Executive for Management TeamTaco Bell Met With Michigan on Parasite Weeks Before RecallMamdani Dismisses Business Leaders Advising NYC’

Fiber laser manufacturer IPG Photonics (NASDAQ:IPGP) will be announcing earnings results this Tuesday morning. Here’s what to expect.

A number of stocks fell in the morning session after the U.S. government announced new tariffs of 10% to 12.5% on 60 trading partners over concerns related to forced labor. The targeted nations include the European Union, Japan, South Korea, and Taiwan—the fundamental pillars of the global semiconductor supply chain. While the U.S. designs many of the world's leading chips, the industry relies heavily on imported specialty chemicals, raw silicon wafers, and multi-million-dollar fabrication equip

Lumentum, IPG Photonics, and nLight have posted strong YTD gains and revenue growth as photonics demand rises for AI, with analysts largely bullish on further upside for all three stocks.

IPGP's Lumibird Medical deal expands its medical laser reach, while rising semiconductor demand and new launches support growth in higher-value markets now.

The robotics and automation fund is down, and its own record suggests a rebound is more common than not, but the ride has rarely been smooth.

IPG Photonics (NASDAQ:IPGP) said it has signed a binding offer with Lumibird SA to acquire Lumibird Medical, a medical laser systems business focused primarily on ophthalmology, in a transaction the company said would expand its exposure to higher-margin medical markets. On a conference call discus

IPG Photonics (IPGP) is back in focus after recent share price moves, with the stock closing at $104.73. Investors are weighing this level in relation to the company’s earnings profile and current valuation signals. See our latest analysis for IPG Photonics. Recent trading has been choppy for IPG Photonics, with the share price falling 2.78% over the last day and down 8.65% over 30 days. The stock is still showing a 39.94% year to date share price return and a 41.13% total shareholder return...

Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them vulnerable.

IPG Photonics stock is caught between two different valuation stories, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to a large gap to the current share price while traditional market multiples lean expensive. Over the past 5 years, IPG Photonics shareholders have seen the stock decline about 47%, which puts extra focus on whether the recent rebound is supported by fundamentals. The company’s valuation can be helped if investors remain confident in its ability to...